| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |